; (ii) advances made pursuant to such research; (iii) Federal activities related to Valley Fever, including— (I) epidemiological activities related to Valley Fever; and (II) basic, clinical, and translational Valley Fever research related to the pathogenesis, prevention, diagnosis, and treatment of Valley Fever; (iv) gaps in Valley Fever research described in clause (iii)(II); (v) the Working Group’s meetings required under paragraph (4); and (vi) the comments received by the Working Group; (B) make recommendations to the Secretary regarding any appropriate changes or improvements to such activities and research